Prevailing importance of the hedgehog signaling pathway and the potential for treatment advancement in sarcoma

Area of Science:

• Oncology
• Developmental Biology
• Molecular Signaling

Background:

• The hedgehog signaling pathway plays a vital role in embryonic development and postnatal growth.
• Aberrant activation of this pathway is observed in cancers like medulloblastoma and basal cell carcinoma.
• Its therapeutic role in other malignancies, including sarcomas, is under investigation.

Purpose of the Study:

• To explore the scientific rationale for hedgehog pathway inhibition in sarcoma treatment.
• To investigate the role of hedgehog signaling in various connective tissue tumors.
• To examine mechanisms of acquired resistance to hedgehog pathway inhibitors.

Main Methods:

• Review of preclinical data and existing literature on hedgehog signaling in cancer.
• Immunohistochemical analysis of Indian hedgehog expression in growth plate chondrocytes and chondrosarcoma.
• Examination of Gli1 transcription factor targets in Ewing sarcoma and rhabdomyosarcoma.
• Analysis of secondary resistance in medulloblastoma mouse models.

Main Results:

• Evidence suggests hedgehog pathway activation in chondrosarcoma, correlating with growth plate chondrocyte differentiation.
• Gli1 is a direct target of EWS-FLI1 in Ewing sarcoma, and its expression is increased in rhabdomyosarcomas.
• Loss of Chr.9q22, encompassing the patched locus, is found in embryonal rhabdomyosarcomas.
• The potential for Gli2 inhibition in osteosarcoma and the pathway's role in ovarian fibromas are discussed.

Conclusions:

• The hedgehog signaling pathway presents a compelling therapeutic target for various sarcomas and connective tissue tumors.
• Understanding pathway activation and resistance mechanisms is crucial for developing effective hedgehog-targeted therapies.
• Further research is warranted to establish hedgehog inhibition as a standard treatment paradigm.